Tests May Spot Most Deadly Prostate Cancers
680685
THURSDAY, Feb. 22 (HealthDay News) -- Physicians may soon be able to identify which men have a more deadly form of prostate cancer, U.S. researchers report.
163585
U.S. black men aged 65 and older run  twice the risk of dying from prostate cancer than comparable  whites, but they are less likely to have a common blood test to  detect the disease, a study said on Monday.
40982
Obese men may get falsely reassuring  results on prostate cancer screening tests, U.S. researchers  said on Monday.
269402
American Cancer Society - Many elderly men are getting screened for prostate  cancer unnecessarily, according to researchers from the San Francisco VA Medical Center.
493271
Prostate cancer (news - web sites) is the second most common type of cancer afflicting American men. And while one in six men will get the disease during
112101
For many men, a routine PSA blood test to screen for prostate cancer has become an annual ritual. Now the developer of the test says it can't be relied on for this purpose, and has led to overly zealous treatment of men with prostate enlargement.
596560
FRIDAY, Sept. 10 (HealthDayNews) -- A review of 20 years' worth of tissue samples casts doubt on the value of prostate-specific antigen (PSA) testing for prostate cancer, a new study contends.
88429
FRIDAY, Sept. 17 (HealthDayNews) -- Prostate cancer is the second most common type of cancer afflicting American men.
520436
Using the largest known prostate cancer data set of patients treated solely with external-beam radiation in the US, radiation oncologists have examined the &quot;PSA bounce&quot; phenomenon and determined that it is not an indicator that men will die of prostate
419738
Prostate cancer (news - web sites) is the second most common type of cancer afflicting American men. And while one in six men will get the disease during his lifetime, only one in 32 will die from it.
410880
New research shows that it's possible to identify men with slowly progressive or latent prostate cancer, reflected by prostate specific antigen (PSA) levels that remain stable or fall over time.
416815
TUESDAY, Dec. 5 (HealthDay News) -- The popular hair-loss drug Propecia can change the results of a common screen for prostate cancer, the prostate-specific antigen (PSA) test, leading to skewed readings that might obscure the presence of disease, a new study found.
476699
Scientists believe they have found a way to make prostate cancer treatment more effective.
30009
The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine researchers.
19891
Scientists are homing in on the genes for prostate cancer after carrying out the biggest study yet to identify the inherited causes of the disease.
299466
Obese men who undergo surgery for prostate cancer are more likely than their non-obese peers to experience a rise in prostate-specific antigen (PSA) levels, a sign that their disease is returning, new research suggests. Moreover, this seems to be true even in cases in which all of the cancer was apparently removed at surgery.
463117
Obese people may be less likely to develop prostate cancer but more likely to die  of it, a study suggests.